Help us: Donate
Follow us on:
×

Tag: Aubrey de Grey

August 31, 2020
In his keynote speech at Ending Age-Related Diseases 2020, Dr. Aubrey de Grey of SENS Research Foundation discusses the current state of the rejuvenation biotechnology industry in the context of the current pandemic. He mentions the failure of Unity Biotechnology's Phase 2 clinical trial for osteoarthritis, COVID-19 and the elderly immune system, the current popularization...
May 15, 2020
There has been a lot happening with the Ending Age-Related Diseases 2020 conference, so today is ideal for sharing some of the exciting things that we have planned. Catch the early bird! First things first: Time is running out to get an Early Bird discount for what will be the biggest online aging research conference...
May 08, 2020
Yesterday, Dr. David Sinclair, Dr. Aubrey de Grey, Tina Woods, former director of the NIA Dr. Felipe Sierra, Daria Khaltourina, and Lifespan.io president Keith Comito discussed the ongoing COVID-19 pandemic and its relationship to healthcare and the future of aging research. After the discussion, our Lifespan Heroes were able to attend and ask questions as...
April 29, 2020
On Thursday, May 7th at noon EDT, on our Facebook page, Lifespan.io will be livestreaming an online roundtable discussion with key leaders of our field to discuss the current pandemic, its relationship to aging research, and how the current situation might impact the future of healthcare. Join Drs. David Sinclair, Aubrey de Grey, former director...
April 29, 2020
In this interview, Brent Nally and Dr. Aubrey de Grey discuss the progress of aging research amid the current pandemic, along with the state of the industry's leaders and major backers - and many other topics related to the science of making people young again. (adsbygoogle = window.adsbygoogle || []).push({});
February 26, 2020
Dr. Aubrey de Grey of SENS Research Foundation was interviewed by the extremely popular Joe Rogan, and they discussed the damage repair approach to aging. Dr. de Grey talked about the current state of aging research, including stem cell therapies, and explained the role of SENS in developing next-generation rejuvenation biotechnology therapies. He also brought...